Please start below.

If you feel unready to get started then just put “TBD” for “to be determined” for sections currently unknown, and prefacing sections that are still under development with “(under development)”.  Then it can be shared which will foster collaboration as early in the process as possible.

After clicking “submit”, invite others to collaborate, and work toward research-design-excellence, rather than mere research-design-completion.  Inviting others in on the design phase, before it’s fully “ready”, is a great way to get key players on board, improve buy-in, and improving study design before it’s too late to make design changes.


    Enter only the items with a red star for now and press submit. Then after you receive an email to validate your account you can edit the other sections, then invite your collaborators to assist in the design of the study.

  • We recommend you include a unique identifier so you can easily find it with a search
  • Please provide any details necessary to do the research: Protocols, dosage, frequency, special instructions
  • Enter which grants, if any, that you will be pursuing, as well as other funding sources
  • List all diseases, illnesses, health conditions, symptoms for which this study is intended to impact.
  • Persons Affected

    The total number of persons affected with a condition that may benefit if the hypothesis is true.

  • in the US
  • in the world
  • Recommendation: Make at least one of these based on directly measurable human-function indicators (example: normal-cell survival, QLQ-c30), in addition to indirect diagnostic measurements (ex: CBC analytics).
  • Please include studies related to this study that demonstrate presumed efficacy of treatment. Provide AMA citations, and PMID with links whenever possible. Separate each with a blank line.
  • Include the treatments the provide the best outcomes, as well as those which are most cost effective. This includes conventional treatments as well as other treatments current under investigation.
  • Cost per patient

    Total cost for this treatment, per patient. This should include clinical costs as well as drug and medical technology costs.

  • Minimum
  • Typical
  • Maximum
  • Treatment Savings Per Patient, if any

    The expected savings per patient for this treatment compared to standard care. This should include clinical costs as well as drug and medical technology costs.

  • Minimum
  • Typical
  • Maximum
  • Include all potential life-threatening contraindicating conditions, as well as the metrics and associated limits for participating in the treatment. These metrics must be intuitively objective, not subject to interpretation.
    Save Draft